ロード中...
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
OBJECTIVE: Atopic dermatitis is a chronic, relapsing inflammatory skin disease characterized by intense pruritus, excoriations and limited therapies. Dupilumab, a monoclonal antibody against interleukin-4 receptor alpha, is a promising new treatment option for atopic dermatitis. We sought to systema...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5752457/ https://ncbi.nlm.nih.gov/pubmed/29312544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22499 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|